Research

Engineering antibody repertoires with precision

We study how pathogen-specific antibody repertoires are generated, remodeled, and deployed — and apply that knowledge to engineer personalized vaccines and immunotherapies.

면역공학 연구실은 항체 레퍼토어를 분자 수준에서 분석하고, 이를 바탕으로 항체 공학과 항체 발굴, 백신·항체 치료제 설계를 연구합니다.

Our core technology

BCR-Seq & Ig-Seq

Two complementary technologies that, together, reveal both the sequences and the abundances of the antibodies that protect us — connecting the B cells that encode antibodies with the antibody proteins actually circulating in serum.

Integrated BCR-Seq and Ig-Seq platform: B cells are analyzed by next-generation sequencing of antibody transcripts with VH:VL pairing, while serum antibodies are affinity-purified and analyzed by high-resolution proteomics, together yielding the sequences and abundances of individual antigen-specific antibodies.
BCR-Seq and Ig-Seq are integrated to recover the sequences and abundances of individual antigen-specific antibodies.

BCR-Seq — the antibody-encoding repertoire

Next-generation sequencing of antibody (BCR) transcripts from B cells, with native VH:VL heavy/light chain pairing, captures the full sequence diversity of the antibody repertoire.

Ig-Seq — the circulating antibody proteome

Affinity purification followed by high-resolution proteomic mass spectrometry quantifies the antibodies actually secreted into serum, revealing which clones dominate the protective response.

Focus areas

What we work on